@article{ca99d4498b1f41a18a5a6c1855411434,
title = "Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney",
abstract = "The X-linked BCL-6 co-repressor (BCOR) gene encodes a key constituent of a variant polycomb repressive complex (PRC) that is mutated or translocated in human cancers. Here we report on the identification of somatic internal tandem duplications (ITDs) clustering in the C terminus of BCOR in 23 of 27 (85%) pediatric clear cell sarcomas of the kidney (CCSK) from two independent cohorts. We profile CCSK tumours using a combination of whole-exome, transcriptome and targeted sequencing. Identical ITD mutations are found in primary and relapsed tumour pairs but not in adjacent normal kidney or blood. Mutant BCOR transcripts and proteins are markedly upregulated in ITD-positive tumours. Transcriptome analysis of ITD-positive CCSKs reveals enrichment for PRC2-regulated genes and similarity to undifferentiated sarcomas harbouring BCOR-CCNB3 fusions. The discovery of recurrent BCOR ITDs defines a major oncogenic event in this childhood sarcoma with significant implications for diagnostic and therapeutic approaches to this tumour.",
author = "Angshumoy Roy and Vijetha Kumar and Barry Zorman and Erica Fang and Haines, {Katherine M.} and HarshaVardhan Doddapaneni and Hampton, {Oliver A.} and Simon White and Bavle, {Abhishek A.} and Patel, {Nimesh R.} and Eldin, {Karen W.} and {John Hicks}, M. and Dinesh Rakheja and Leavey, {Patrick J} and Skapek, {Stephen X} and Amatruda, {James F} and Nuchtern, {Jed G.} and Chintagumpala, {Murali M.} and Wheeler, {David A.} and Plon, {Sharon E.} and Pavel Sumazin and Parsons, {D. Williams}",
note = "Funding Information: This work was supported by the National Institutes of Health (NHGRI/NCI 1U01HG006485), the Cancer Prevention and Research Institute of Texas (RP120685-P1, RP120685-AC and RP120685-C1) and a Stand Up To Cancer St Baldrick{\textquoteright}s Pediatric Dream Team Translational Research Grant (SU2CAACR-DT1113; Stand Up To Cancer is a programme of the Entertainment Industry Foundation administered by the American Association for Cancer). The results published here are in part based on data generated by the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative managed by the NCI. Information about TARGET can be found at http://ocg.cancer.gov/programs/target. We acknowledge Pamela Parsons for technical assistance. The BCOR-184 antibody was a kind gift from Dr Vivian Bardwell. Publisher Copyright: {\textcopyright} 2015 Macmillan Publishers Limited. All rights reserved.",
year = "2015",
month = nov,
day = "17",
doi = "10.1038/ncomms9891",
language = "English (US)",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
}